# The PROTECT-HIE Pilot Trial

> **NCT07406477** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Alberta** · enrollment: 40 (estimated)

## Conditions studied

- Hypoxic-ischemic Encephalopathy (HIE)

## Interventions

- **DRUG:** Dobutamine
- **DIAGNOSTIC_TEST:** TnECHO

## Key facts

- **NCT ID:** NCT07406477
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07406477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07406477, "The PROTECT-HIE Pilot Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07406477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*